Gilead Sciences Aktie
81,88
EUR
-2,25
EUR
-2,67
%
88,51
USD
+0,05
USD
+0,06
%
Gilead Sciences Aktie Analyse
| 11.11.09 | Gilead Sciences neutral | Goldman Sachs Group Inc. | |
| 06.11.09 | Gilead Sciences | boerse.de-Aktienbrief | |
| 30.10.09 | Gilead Sciences | Der Aktionär | |
| 22.10.09 | Gilead Sciences neutral | Goldman Sachs Group Inc. | |
| 21.10.09 | Gilead Sciences outperform | Credit Suisse Group | |
| 21.10.09 | Gilead Sciences underperform | Wedbush Morgan Securities Inc. | |
| 23.07.09 | Gilead Sciences outperform | Wedbush Morgan Securities Inc. | |
| 22.07.09 | Gilead Sciences outperform | Credit Suisse Group | |
|
Werbung
|
|||
| 03.07.09 | Gilead Sciences einkaufen | boerse.de-Aktienbrief | |
| 26.06.09 | Gilead Sciences outperform | Robert W. Baird & Co. Incorporated | |
| 14.05.09 | Gilead Sciences | Focus Money | |
| 11.05.09 | Gilead Sciences outperform | Robert W. Baird & Co. Incorporated | |
| 08.05.09 | Gilead Sciences | boerse.de-Aktienbrief | |
| 05.05.09 | Gilead Sciences halten | Global Biotech Investing | |
| 29.04.09 | Gilead Sciences | Der Aktionär | |
| 22.04.09 | Gilead Sciences buy | Wedbush Morgan Securities Inc. | |
| 22.04.09 | Gilead Sciences equal-weight | Barclays Capital | |
| 22.04.09 | Gilead Sciences outperform | Robert W. Baird & Co. Incorporated | |
| 15.04.09 | Gilead Sciences buy | ThinkEquity Partners LLC | |
| 07.04.09 | Gilead Sciences outperform | Robert W. Baird & Co. Incorporated | |
| 06.04.09 | Gilead Sciences outperform | Credit Suisse Group | |
| 03.04.09 | Gilead Sciences buy | Wedbush Morgan Securities Inc. | |
| 01.04.09 | Gilead Sciences buy | Citigroup Corp. | |
| 27.03.09 | Gilead Sciences buy | Citigroup Corp. | |
| 20.03.09 | Gilead Sciences outperform | Robert W. Baird & Co. Incorporated | |
| 19.03.09 | Gilead Sciences buy | Wedbush Morgan Securities Inc. | |
| 18.03.09 | Gilead Sciences buy | Wedbush Morgan Securities Inc. | |
| 16.03.09 | Gilead Sciences outperform | Robert W. Baird & Co. Incorporated | |
| 13.03.09 | Gilead Sciences hold | Jefferies & Company Inc. | |
| 13.03.09 | Gilead Sciences outperform | Credit Suisse Group | |
| 13.03.09 | Gilead Sciences outperform | RBC Capital Markets | |
| 13.03.09 | Gilead Sciences buy | Wedbush Morgan Securities Inc. | |
| 13.03.09 | Gilead Sciences buy | Citigroup Corp. | |
| 12.03.09 | Gilead Sciences outperform | Robert W. Baird & Co. Incorporated | |
| 12.03.09 | Gilead Sciences market outperform | Rodman & Renshaw, LLC | |
| 13.02.09 | Gilead Sciences | boerse.de-Aktienbrief | |
| 29.01.09 | Gilead Sciences buy | UBS AG | |
| 28.01.09 | Gilead Sciences outperform | Credit Suisse Group | |
| 28.01.09 | Gilead Sciences buy | Stanford Financial Group, Inc. | |
| 28.01.09 | Gilead Sciences market outperform | Rodman & Renshaw, LLC | |
| 27.01.09 | Gilead Sciences buy | Citigroup Corp. | |
| 26.01.09 | Gilead Sciences | Euro am Sonntag | |
| 26.01.09 | Gilead Sciences market outperform | Rodman & Renshaw, LLC | |
| 05.01.09 | Gilead Sciences buy | Needham & Company, LLC | |
| 29.12.08 | Gilead Sciences buy | Citigroup Corp. | |
| 23.12.08 | Gilead Sciences buy | Stanford Financial Group, Inc. | |
| 19.12.08 | Gilead Sciences | boerse.de-Aktienbrief | |
| 17.12.08 | Gilead Sciences buy | Merrill Lynch & Co., Inc. | |
| 16.12.08 | Gilead Sciences outperform | Credit Suisse Group | |
| 16.12.08 | Gilead Sciences buy | Merriman Curhan Ford & Co | |